[Kidney Disease and Laboratory Examinations--Opening Remarks: For Better Understanding of CKD]

Area of Science:

• Nephrology
• Internal Medicine
• Clinical Diagnostics

Context:

• Chronic kidney diseases (CKD) are significant risk factors for end-stage renal failure, cardiovascular diseases, and mortality.
• Previous CKD diagnostic criteria (NKF K/DOQI, 2002) relied solely on Glomerular Filtration Rate (GFR), limiting prognostic accuracy due to lack of cause and albuminuria grading.
• The 2012 KDIGO CKD guideline introduced a disease category for diabetes mellitus and a microalbuminuria scoring system, enhancing diagnostic and prognostic capabilities.

Purpose:

• To enhance understanding of the causes and evaluation methods for chronic kidney diseases (CKD).
• To discuss advancements in CKD diagnosis and prognosis, particularly the integration of albuminuria assessment.
• To provide insights into kidney pathology, urine sample examination, urinary biomarkers, and GFR estimation.

Summary:

• The symposium addressed the evolution of CKD diagnostic criteria, moving from GFR-only assessments to incorporating albuminuria grading as per the 2012 KDIGO guidelines.
• Discussions covered kidney pathology, urine analysis, novel urinary biomarkers, and GFR estimation techniques for comprehensive CKD evaluation.
• The revised guidelines offer improved prognostic accuracy, especially for patients with diabetes mellitus, benefiting both specialists and general practitioners.

Impact:

• Improved diagnostic accuracy and prognostic assessment for chronic kidney diseases (CKD).
• Enhanced clinical decision-making for physicians managing CKD patients, particularly those with diabetes.
• Facilitates better patient understanding and management of CKD, reducing risks of renal failure and cardiovascular complications.